Clinical significance of prognostic nutritional index (PNI) in malignant melanoma
Nutrition and inflammation play a crucial role in the development of cancer. The prognostic value of the prognostic nutritional index (PNI) has been confirmed in some types of human cancers. However, few studies are available indicating its prognostic power in patients with malignant melanoma (MM). Thus, we aimed to identify baseline peripheral blood biomarkers to predict the outcome of MM patients
Material and methods
Data of 101 patients with MM were evaluated retrospectively. Associations between clinical and histopathological parameters with overall survival (OS) and progression-free survival (PFS) were analyzed using Kaplan–Meier curves and compared by the log-rank test. The optimal cutoff values were determined by a receiver operating characteristic (ROC) curve analysis. Neutrophil–lymphocyte ratio (NLR), systemic immune-inflammation index (SII) and PNI were grouped based on a cutoff points 2.18, 547.1, and 40.1, respectively. Univariate and multivariate analyses were used to assess their prognostic values for overall survival (OS).
Lower NLR ( < 2.18), SII ( < 547.1) and higher PNI ( ≥ 40.1) were linked with a longer PFS and OS in patients with MM, as reflected in the Kaplan–Meier analyses. In univariate analysis, TNM stage, Breslow thickness, Clark stage, ulceration, Ki67 status, LDH, NLR, SII, and PNI were significantly associated with OS. Multivariate analysis identified TNM stage, ulceration, LDH and PNI as an independent predictor of OS in patients with MM.
PNI can be regarded as a novel independent prognostic factor for predicting OS in MM.
KeywordsMalignant melanoma Prognostic nutritional index Neutrophil–lymphocyte ratio Systemic immune-inflammation index
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 9.El-Hag A, Clark RA (1987) Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 139(7):2406–2413Google Scholar
- 10.Jabłońska E, Kiluk M, Markiewicz W et al (2001) TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients. Arch Immunol Ther Exp 49(1):63–69Google Scholar
- 12.Faria SS, Fernandes PC Jr, Silva MJB et al (2016) The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience 10:702Google Scholar
- 18.Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85(9):1001–1005Google Scholar
- 28.Weinstein D, Leininger J, Hamby C et al (2014) Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol 7(6):13–24Google Scholar
- 34.Tomita M, Ayabe T, Maeda R et al (2018) Systemic immune-inflammation index predicts survival of patients after curative resection for non-small cell lung cancer. Vivo 32(3):663–667Google Scholar
- 37.Huang L, Liu S, Lei Y et al (2016) Systemic immune-inflammation index, thymidine phosphorylase and survival of localized gastric cancer patients after curative resection. Oncotarget 7(28):44185–44193Google Scholar
- 38.Zhong JH, Huang DH, Chen ZY (2017) Prognostic role of systemic immune-inflammation index in solid tumors: a systematic review and meta-analysis. Oncotarget 8(43):75381–75388Google Scholar